Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography

New England Journal of Medicine

Volumn 339, Issue 27, 1998, Pages 1972-1978

  Callister, Tracy Q ^a   Raggi, Paolo ^a,c   Cooil, Bruce ^b   Lippolis, Nicholas J ^a   Russo, Donald J ^a  

^a Electron Beam Tomography Research Foundation   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c EBT Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DRUG EFFECT; ELECTRON BEAM; ENZYME INHIBITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SECONDARY PREVENTION;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CALCINOSIS; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032585608     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812313392703     Document Type: Article

References (50)

1. Superko HR, Krauss RM. Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994;90:1056-69.
2. Gould KL. Reversal of coronary atherosclerosis: clinical promise as the basis for noninvasive management of coronary artery disease. Circulation 1994;90:1558-71.
3. Blankenhorn DH, Azen SP, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993;119:969-76.
4. The MAAS Investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994;344:633-8. [Erratum, Lancet 1994;344:762.]
5. Watts GF, Lewis B, Jackson P, et al. Relationship between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Can J Cardiol 1995;11:Suppl G:110G-114G.
6. Brown BG, Hillger L, Zhao XQ, Poulin D, Albers JJ. Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease: observations from the FATS Trial: Familial Atherosclerosis Treatment Study. Ann N Y Acad Sci 1995; 748:407-17.
7. Jukema JW, Bruschke AVG, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995;91:2528-40.
8. Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial. Circulation 1994;89:959-68.
9. Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 1995;26:1133-9.
10. Herd JA, Ballantyne CM, Farmer JA, et al. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCSA]). Am J Cardiol 1997;80:278-86.
11. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21.
12. Tanenbaum SR, Kondos GT, Veselik KE. Detection of calcific deposits in coronary arteries by ultrafast computed tomography and correlation with angiography. Am J Cardiol 1989;63:870-2.
13. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
14. Breen JF, Sheedy PF II, Schwartz RS, et al. Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology 1992;185:435-9.
15. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol 1992;20:1118-26.
16. Mautner GC, Mautner SL, Froehlich J, et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology 1994;192:619-23.
17. Janowitz WR, Agatston AS, Kaplan G, Viamonte M Jr. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993;72:247-54.
18. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 1995;15:2157-62.
19. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126-33.
20. Wang S, Detrano RC, Secci A, et al. Detection of coronary calcification with electron-beam computed tomography: evaluation of interexamination reproducibility and comparison of three image-acquisition protocols. Am Heart J 1996;132:550-8.
21. Janowitz WR, Agatston AS, Viamonte M Jr. Comparison of serial quantitative evaluation of calcified coronary artery plaque by ultrafast computed tomography in persons with and without obstructive coronary artery disease. Am J Cardiol 1991;68:1-6.
22. Hernigou A, Challande P, Boudeville JC, Sene V, Grataloup C, Plainfosse MC. Reproducibility of coronary calcification detection with electron beam computed tomography. Eur Radiol 1996;6:210-6.
23. Kajinami K, Seki H, Takekoshi N, Mabuchi H. Quantification of coronary artery calcification using ultrafast computed tomography: reproducibility of measurements. Coron Art Dis 1993;4:1103-8.
24. Devries S, Wolfkiel C, Shah V, Chomka E, Rich S. Reproducibility of the measurement of coronary calcium with ultrafast computed tomography. Am J Cardiol 1995;75:973-5.
25. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998;208:807-14.
26. Rumberger JA, Simons DB, Edwards WD, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary calcium volume by electron beam CT quantifies coronary plaque volume. Circulation 1994;90:Suppl I:I-300. abstract.
27. Sangiorgi G, Srivatsa SS, Staab M, et al. Total coronary calcified volume is highly correlated with total plaque volume: a histologic study of 723 segments. J Am Coll Cardiol 1995;25:Suppl:386A. abstract.
28. Raya SP, Udupa JK. Shape-based interpolation of multidimensional objects. IEEE Trans Med Imaging 1990;9:32-42.
29. Raya SP, Udupa JK, Barrett WA. A PC-based 3-D imaging system: algorithms, software, and hardware considerations. Comput Med Imaging Graph 1990;14:353-70.
30. Raya SP. Low-level segmentation of 3D magnetic resonance brain images: a rule-based system. IEEE Trans Med Imaging 1990;9:327-37
31. Larsen RJ, Marx ML, Cooil B. Statistics for applied problem solving and decision making. Pacific Grove, Calif.: Duxbury, 1997:633-74.
32. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
33. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP. Remodeling of coronary arteries in human and nonhuman primates. JAMA 1994;271:289-94.
34. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431-8.
35. Wexler L, Brundage B, Grouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications: a statement for health professionals from the American Heart Association Writing Group. Circulation 1996;94:1175-92.
36. Schmermund A, Baumgart D, Gorge G, et al. Measuring the effect of risk factors on coronary atherosclerosis: coronary calcium score versus angiographic disease severity. J Am Coll Cardiol 1998;31:1267-73.
37. Packard CJ. Relationship between LDL-C changes and CHD event reduction with pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1997;96:Suppl I:I-107. abstract.
38. Superko HR. New aspects of risk factors for the development of atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a). Curr Opin Cardiol 1995;10:347-54.
39. Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 1997;157:1170-6.
40. Cobbaert C, Jukema JW, Zwinderman AH, Withagen AJ, Lindemans J, Bruschke AV. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol: Regression Growth Evaluation Statin Study (REGRESS) Study Group. J Am Coll Cardiol 1997;30:1491-9.
41. Frohlich JJ. Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: assessment and treatment. Can J Cardiol 1995;11:Suppl C:18C-23C.
42. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 1995;91:284-90.
43. Davies MJ. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 1996;82:1-32.
44. Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997;8:320-8.
45. Levenson J, Giral P, Megnien JL, Gariepy J, Plainfosse MC, Simon A. Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men. Arterioscler Thromb Vasc Biol 1997;17:45-50.
46. Hatanaka K, Li XA, Masuda K, Yutani C, Yamamoto A. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method. Pathol Int 1995;45:635-41.
47. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A 1983;80:6386-9.
48. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-4. [Erratum, BMJ 1995;311:985.]
49. Niemela S, Karttunen T, Korhonen T, et al. Could Helicobaeter pylori infection increase the risk of coronary heart disease by modifying lipid serum concentrations? Heart 1996;75:573-5.
50. Pasceri V, Cammarota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998;97: 1675-9.